Literature DB >> 20528760

Volume reduction in routine cord blood banking.

Pilar Solves1, Vicente Mirabet, Roberto Roig.   

Abstract

Umbilical cord blood (UCB) is an alternative source of hematopoietic progenitors for transplantation in the treatment of haematological malignancies, marrow failure, immunodeficiencies, hemoglobinopathies and inherited metabolic diseases. It has greatly contributed to increase the feasibility to transplantation for many patients in need. To date, more than 20,000 UCB transplants have been performed on children and adults, and more than 400,000 UCB units are available in more than 50 public CB banks. One of the most important objectives of banks is to cryopreserve and store high quality UCB units. Volume reduction is a usual process in cord blood banking that has some advantages as reducing the storage space and the DMSO quantity in final product. Volume reduction methodology must guarantee high cell recovery and red blood cell (RBC) depletion by reducing the UCB units to a standard volume. Hydroxyethyl starch (HES) sedimentation was the first method developed for this purpose by the New York Cord Blood Bank and implemented in many banks worldwide. The semi-automated top and bottom system, usually used for blood fractionation was further developed to simplify and short the process. Later, automatic devices as SEPAX and AXP have been developed in last years specifically for UCB volume reduction purpose. This review critically analyses the advantages and disadvantages of the different procedures. All of them have been used in Valencia Cord Blood Bank along 10 years. In general, automatic devices are preferred because of compliance with cGTP, closed systems, higher reproducibility and less influence of technician.

Entities:  

Mesh:

Year:  2010        PMID: 20528760     DOI: 10.2174/157488810793351703

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  3 in total

1.  Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study.

Authors:  Pilar Solves; Dolores Planelles; Vicente Mirabet; Amando Blanquer; Francisco Carbonell-Uberos
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

Review 2.  The role and potential of umbilical cord blood in an era of new therapies: a review.

Authors:  Santiago Roura; Josep-Maria Pujal; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  Stem Cell Res Ther       Date:  2015-07-02       Impact factor: 6.832

3.  Effects of Cryopreservation Duration on the Outcome of Single-Unit Cord Blood Transplantation.

Authors:  Tang-Her Jaing; Shih-Hsiang Chen; Yu-Chuan Wen; Tsung-Yen Chang; Ya-Chun Yang; Pei-Kwei Tsay
Journal:  Cell Transplant       Date:  2018-05-08       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.